GlassScriptPhysician profile
Rekha Pinto
NPI 1215122775
$9,898.97
in general payments reported to CMS, 2019-2025
42 companies · $1,339 in 2025
The $1,339 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,498 · 2020: $543 · 2021: $1,443 · 2022: $2,451 · 2023: $1,295 · 2024: $1,331 · 2025: $1,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,865 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,864.93 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $1,837.69 | 2021-2025 | Ffrct |
| Janssen Pharmaceuticals, INC | $994.32 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $810.50 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $699.40 | 2019-2025 | Farxiga, Andexxa, Lokelma |
| Novartis Pharmaceuticals Corporation | $690.33 | 2019-2025 | |
| Pfizer INC. | $629.96 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $464.28 | 2019-2025 | Opsumit, Uptravi |
| Amgen INC. | $459.10 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $415.11 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $365.56 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $321.65 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $250.42 | 2021-2025 | |
| Amarin Pharma, INC. | $246.30 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $166.16 | 2022-2025 | Verquvo |
| Scpharmaceuticals INC. | $163.27 | 2023-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rekha Pinto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.